LOW AND STEADY: The CECC reported a 12.1% drop in local COVID-19 cases from Sunday last week, and said it would review its remaining mask mandates next monthBy Lee I-chia / Staff reporter
A study performed in Taiwan found that two kinds of Traditional Chinese Medicine (TCM) formulations significantly reduced disease progression in patients infected with the Wuhan coronavirus [.]
A Chinese medicine-based herbal formula developed in Taiwan called Taiwan Chingguan Erhau (清冠二號), or NRICM102, could reduce the mortality rate of COVID-19 cases who experience severe symptoms by 50 percent, National Research Institute of Chinese Medicine (NRICM) director Su Yi-chang (蘇奕彰) said.
Su talked about the treatment on Sunday at the Taipei Traditional Chinese Medicine International Forum, saying that following the success of Taiwan Chingguan Yihau (清冠一號), or NRICM101, the institute is applying for patents and trademarks for the new formulation.
In 2020, permission was granted to export Taiwan Chingguan Yihau, and it has been sold in more than 50 countries with
By Tsai Si-pei and Liu Tzu-hsuan / Staff reporter, with staff writerA Chinese medicine-based herbal formula developed in Taiwan called Taiwan Chingguan Erhau （清冠二號）, or NRICM102, could reduce the mortality rate of COVID-19 cases who experience severe symptoms by 50 percent, National Research Institute of Chinese Medicine （NRICM） director Su Yi-chang （蘇奕彰） said.